This invention relates to a method for administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals in a transdermal device or formulation comprising topically administering with said systemic agent an effective amount of a membrane penetration enhancer having the structural formula
wherein X is selected from the group consisting of oxygen and sulfur; Rʹ is H or a lower alkyl group having 1-4 carbon atoms; m is 2-6; and n is 0-17.
本发明涉及一种在透皮装置或制剂中通过人和动物的皮肤或粘膜施用全身活性剂(包括治疗剂)的方法,包括与所述全身性制剂一起局部施用有效量的膜渗透
促进剂,其结构式为 其中 X 选自由氧和
硫组成的组;Rʹ 是 H 或具有 1-4 个碳原子的低级烷基;m 是 2-6;n 是 0-17。